A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes
G Bandoli, K Palmsten, CJF Smith… - Rheumatic Disease …, 2017 - rheumatic.theclinics.com
Corticosteroids are administered in pregnancy for their immunosuppressive and
antiinflammatory effects. 1 They are used to treat symptoms of autoimmune conditions …
antiinflammatory effects. 1 They are used to treat symptoms of autoimmune conditions …
Emerging progress in nausea and vomiting of pregnancy and hyperemesis gravidarum: challenges and opportunities
C Liu, G Zhao, D Qiao, L Wang, Y He, M Zhao… - Frontiers in …, 2022 - frontiersin.org
Nausea and vomiting of pregnancy (NVP) is a common condition that affects up to 70% of
pregnant women. Hyperemesis gravidarum (HG) is considered the serious form of NVP …
pregnant women. Hyperemesis gravidarum (HG) is considered the serious form of NVP …
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline
PW Speiser, R Azziz, LS Baskin… - The Journal of …, 2010 - academic.oup.com
Objective: We developed clinical practice guidelines for congenital adrenal hyperplasia
(CAH). Participants: The Task Force included a chair, selected by The Endocrine Society …
(CAH). Participants: The Task Force included a chair, selected by The Endocrine Society …
Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on …
KJ Jenkins, A Correa, JA Feinstein, L Botto, AE Britt… - Circulation, 2007 - Am Heart Assoc
Prevention of congenital cardiovascular defects has been hampered by a lack of information
about modifiable risk factors for abnormalities in cardiac development. Over the past …
about modifiable risk factors for abnormalities in cardiac development. Over the past …
Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta‐analysis of epidemiological studies
L Park‐Wyllie, P Mazzotta, A Pastuszak, ME Moretti… - …, 2000 - Wiley Online Library
Background: Corticosteroids are first-line drugs for the treatment of a variety of conditions in
women of childbearing age. Information regarding human pregnancy outcome with …
women of childbearing age. Information regarding human pregnancy outcome with …
Side effects of corticosteroid therapy
AL Buchman - Journal of clinical gastroenterology, 2001 - journals.lww.com
Background Corticosteroids have been used for the treatment of inflammatory bowel
disease since the late 1940s. Upwards of 80% of patients may respond acutely to treatment …
disease since the late 1940s. Upwards of 80% of patients may respond acutely to treatment …
Hydroxychloroquine early in pregnancy and risk of birth defects
Background Hydroxychloroquine is generally considered safe in pregnancy for the treatment
of rheumatic conditions, but studies have been too small to evaluate teratogenicity …
of rheumatic conditions, but studies have been too small to evaluate teratogenicity …
Classification, epidemiology, and genetics of orofacial clefts
SE Watkins, RE Meyer… - Clinics in plastic …, 2014 - plasticsurgery.theclinics.com
There is considerable ambiguity in the use of terminology when referring to orofacial clefts
(OFCs). Many clinicians incorrectly refer to OFCs as deformities, which are said to be the …
(OFCs). Many clinicians incorrectly refer to OFCs as deformities, which are said to be the …
Anti-inflammatory and immunosuppressive drugs and reproduction
M Østensen, M Khamashta, M Lockshin, A Parke… - Arthritis research & …, 2006 - Springer
Rheumatic diseases in women of childbearing years may necessitate drug treatment during
a pregnancy, to control maternal disease activity and to ensure a successful pregnancy …
a pregnancy, to control maternal disease activity and to ensure a successful pregnancy …
Non-syndromic cleft palate: an overview on human genetic and environmental risk factors
M Martinelli, A Palmieri, F Carinci… - Frontiers in cell and …, 2020 - frontiersin.org
The epithelial and mesenchymal cells involved in early embryonic facial development are
guided by complex regulatory mechanisms. Any factor perturbing the growth, approach and …
guided by complex regulatory mechanisms. Any factor perturbing the growth, approach and …